Skip to content
RxMonitor home

Medication

Cystadane

DIN 02238526 · Recordati Rare Diseases Canada Inc

What it is

Active ingredients
Form and route
Powder For Solution · Oral
Schedule
PRESCRIPTION
Authorised since
1998-08-11

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

No other medication authorised in Canada shares this active ingredient.

Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.

Watch this medication

Ontario Drug Benefit coverage

As of 31 July 2026

This medication is not listed on the Ontario Drug Benefit formulary.

Not on the formulary is not the same as not covered. Private and workplace insurance, federal programs such as Non-Insured Health Benefits and Veterans Affairs, and every other province’s public plan are all outside what this page shows — Ontario is the only province RxMonitor holds coverage data for. Ontario may also fund a product that is not on the formulary through the Exceptional Access Program.

Check this medication on Ontario’s own coverage search →

Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.

Reported side effects

RxMonitor does not show reported side effects.

Health Canada collects voluntary reports of suspected side effects in the Canada Vigilance database. RxMonitor does not summarise them, because a count of reports is not a rate and the most-reported term for a medication is often the condition it is prescribed for — for a reliever inhaler, the most reported term is asthma. Nothing here should be read as a list of this medication’s side effects, or as evidence that it has few. The product monograph and a pharmacist are the sources for that.

Search Health Canada’s adverse reaction database →

How it is classified

Anatomical main group
Alimentary tract and metabolism
ATC code
A16AA06

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of A16AA06, see the WHO ATC/DDD Index.

Recalls and safety alerts

As of 12 August 2026

No Health Canada recall has been matched to this product.

This is not a statement that no recall exists for this medication. Health Canada’s recalls data carries no DIN and no company name, so notices are matched on wording alone — and 1,386 of the 2,306 drug notices in the feed could not be matched to any product at all. Check Health Canada’s own search before concluding anything.

Search Health Canada recalls for Cystadane
How RxMonitor matches recalls, and how often it fails

Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.